Enduring non-rapid eye movement sleep fragmentation following methotrexate chemotherapy in cancer-naïve mice

Methotrexate promotes NREM sleep fragmentation, without affecting sleep quality or time spent asleep. This effect is stronger in males. These data suggest that chemotherapy can cause long-term sleep disruption independent of cancer presence.

Authors

Institutions

Publication Details

Journal
SLEEP
Published
2025-03-20
DOI
https://doi.org/10.1093/sleep/zsaf073
Citations
3
Primary Topic
Sleep and Wakefulness Research
Type
article
Field-Weighted Citation Impact
4.29
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Enduring non-rapid eye movement sleep fragmentation following methotrexate chemotherapy in cancer-naïve mice

Erin M. Gibson, Adrian M. Gomez, Jeremy C. Borniger, Adrian Berisha et al.
3 citations
SLEEP
Sleep and Wakefulness Research
4.29
article

Enduring non-rapid eye movement sleep fragmentation following methotrexate chemotherapy in cancer-naïve mice

Erin M. Gibson, Adrian M. Gomez, Jeremy C. Borniger, Adrian Berisha, Leah Boyd
article en
3 citations

Abstract

Methotrexate promotes NREM sleep fragmentation, without affecting sleep quality or time spent asleep. This effect is stronger in males. These data suggest that chemotherapy can cause long-term sleep disruption independent of cancer presence.

SLEEPVol. 48(7)
Palo Alto University (US), Cold Spring Harbor Laboratory (US), Stanford University (US)
Good health and well-being
Openalex Percentile: Top 7%
Sleep and Wakefulness Research
4.29
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.